THE STRATEGIC IMPORTANCE OF IN-HOUSE PRODUCT DEVELOPMENT IN MAXILLOFACIAL PRACTICE
DOI:
https://doi.org/10.32782/health-2025.2.31Keywords:
hydroxyapatite, medical entrepreneurship, proprietary products, dental management, innovation in practice, biomimetic materials.Abstract
The article explores the strategic importance of in-house product development in private maxillofacial practice to integrate clinical innovation with business sustainability. The study identifies that the traditional service-based healthcare model limits profitability due to dependence on chair-time, local competition, and operational costs. Conversely, developing proprietary, biocompatible products – particularly hydroxyapatite-based toothpaste and mouthwash – enhances revenue diversification, patient loyalty, and clinic brand value. This study aims to examine both the clinical and entrepreneurial rationale for in-house product creation and propose a practical framework for private dental and surgical clinics. The research applies a mixed-method approach combining literature review, international benchmarking, and a case study of a Ukrainian maxillofacial clinic introducing hydroxyapatite oral care products. Results demonstrate a 36% reduction in dentin hypersensitivity, a 72% increase in patient trust, and new B2B collaborations contributing up to 18% of total clinic revenue. The findings confirm that proprietary formulations improve clinical outcomes and transform private clinics into innovation-driven enterprises with sustainable business models. The study concludes that in-house product development represents a dual pathway for strengthening clinical quality and financial resilience, serving as a model for futureoriented private healthcare systems.
References
Amaechi, B. T., et al. (2021). Hydroxyapatite and its preventive effects on dental caries: A systematic review. European Journal of Dentistry, 15(1), 1–8. https://doi.org/10.1055/s-0040-1717001
Cardinal Health. (2023). Private-label healthcare products: Margins and growth trends. https://www.cardinalhealth.com
Christensen, C. M., Grossman, J. H., & Hwang, J. (2020). The innovator’s prescription: A disruptive solution for health care. McGraw-Hill.
Cooper, R. G. (2019). Winning at new products: Creating value through innovation (5th ed.). Basic Books.
De Melo Alencar, C., et al. (2019). Clinical effectiveness of toothpastes containing nanohydroxyapatite for dentin hypersensitivity. Scientific Reports, 9, Article 16987. https://doi.org/10.1038/s41598-019-53511-3
Di Stefano, G., Peteraf, M., & Verona, G. (2020). Dynamic capabilities and the evolution of business model innovation in healthcare startups. Long Range Planning, 53(3), 101871. https://doi.org/10.1016/j.lrp.2020.101871
European Commission. (2025). Scientific Committee on Consumer Safety (SCCS) — Opinion on hydroxyapatite (nano). https://health.ec.europa.eu
Ferreira, X., et al. (2023). Determinants of patient satisfaction in dental services: A systematic review. International Journal of Dental Research and Practice, 6(4), 211–223.
Garcia-Godoy, F., & Hicks, M. J. (2020). Maintaining the integrity of enamel and dentin: The importance of hydroxyapatite-based materials. Journal of Clinical Dentistry, 31(S1), S1–S7.
Grant, R. M. (2019). Contemporary strategy analysis: Text and cases edition (10th ed.). Wiley.
Harris, B. (2024, August 19). Add value to your dental practice by adding revenue streams. Dental Economics.https://www.dentaleconomics.com/sponsored/article/55091910/add-value-to-your-dental-practice-by-adding-revenue-streams
Holland & Hart. (2023). Navigating anti-kickback and self-referral risks in private healthcare retail. https://www.hollandhart.com
Hsu, J. Y., Lin, S., & Tsai, C. H. (2022). Effects of physician online reputation and expertise cues on patient selection. Health Marketing Quarterly, 39(2), 150–166. https://doi.org/10.1080/07359683.2022.2039046
International Organization for Standardization. (2007). ISO 22716:2007 — Cosmetics — Good manufacturing practices (GMP) — Guidelines on good manufacturing practices. ISO.
Kaplan, R. S., & Norton, D. P. (2001). The strategy-focused organization: How balanced scorecard companies thrive in the new business environment. Harvard Business School Press.
Kim, H., Park, E., & Lee, J. (2021). Innovation management in dental care services: The impact of R&D and product testing on clinic performance. Healthcare Management Review, 46(4), 275–284. https://doi.org/10.1097/HMR.0000000000000271
Limeback, H., et al. (2023). Remineralization and dentin tubule occlusion effects of hydroxyapatite dentifrices: A meta-analysis. Frontiers in Dental Medicine, 4, Article 1065934. https://doi.org/10.3389/fdmed.2023.1065934
O’Hagan-Wong, K., et al. (2021). The use of hydroxyapatite toothpaste to prevent dental caries. European Journal of Dentistry / PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930857/
Ortiz, M. (2019). Trust and authority in healthcare decision-making: The role of professional endorsement. Journal of Health Communication, 24(6), 518–527. https://doi.org/10.1080/10810730.2019.1620278
Osterwalder, A., & Pigneur, Y. (2010). Business model generation: A handbook for visionaries, game changers, and challengers. Wiley.
Paszynska, E., Pawinska, M., Enax, J., Meyer, F., Schulze zur Wiesche, E., May, T. W., Amaechi, B. T., Limeback, H., Hernik, A., Otulakowska-Skrzynska, J., Krahel, A., Kaminska, I., Lapinska-Antonczuk, J., Stokowska, E., & Gawriolek, M. (2023). Caries-preventing effect of a hydroxyapatite toothpaste in adults: An 18-month double-blinded randomized clinical trial. Frontiers in Public Health, 11, Article 1199728. https://doi.org/10.3389/fpubh.2023.1199728
Porter, M. E., & Teisberg, E. O. (2007). Changing the Organization of Health Care—Reply. JAMA, 298(3), 286-288.
Shrestha, B., & Park, J. (2019). University-clinic collaboration for innovation in dental materials development. Journal of Technology Transfer, 44(5), 1381–1397. https://doi.org/10.1007/s10961-018-9701-7
Stanciu, A., et al. (2023). Online reputation management in oral and maxillofacial surgery: Systematic review. BMC Oral Health, 23, Article 754. https://doi.org/10.1186/s12903-023-03422-1
U.S. Food and Drug Administration. (2025). Guidelines for over-the-counter oral care products and cosmetic claims compliance. https://www.fda.gov
Zhang, L., Li, Y., & Chen, Z. (2025). Patient-reported outcome measures (PROMs) in dental care: Implications for satisfaction and engagement. Journal of Dental Research and Practice, 8(1), 34–46.
Zhang, Y., Zhou, X., & Chen, Y. (2022). Biomimetic hydroxyapatite in enamel restoration: Clinical applications and market trends. Journal of Applied Oral Science, 30, e20220145. https://doi.org/10.1590/1678-7757-2022-0145
